Stay updated on FT538 with Daratumumab in AML Clinical Trial
Sign up to get notified when there's something new on the FT538 with Daratumumab in AML Clinical Trial page.

Latest updates to the FT538 with Daratumumab in AML Clinical Trial page
- Check4 days agoChange DetectedA new latest revision entry v3.6.3 is added to the version history, replacing the previous v3.6.2.SummaryDifference0.1%

- Check11 days agoChange DetectedA new revision tag v3.6.2 was added to the study record history, indicating an update to the record; the older v3.6.0 tag was removed from the history.SummaryDifference0.1%

- Check18 days agoNo Change Detected
- Check25 days agoChange DetectedRecruitment status now shows the study is no longer enrolling participants. The record history updates to include revision v3.6.0 and removes the previous revision v3.5.5 entry.SummaryDifference0.4%

- Check32 days agoChange DetectedThe record history adds a new revision label, Revision: v3.5.5, updating the version shown in the history. It replaces the previous Revision: v3.5.4, reflecting a minor administrative update to the page metadata.SummaryDifference0.1%

- Check54 days agoChange DetectedAdded a new revision entry 'Revision: v3.5.4' to the study record history and removed the previous 'Revision: v3.5.3'. This update updates the history to reflect the latest revision of the study record.SummaryDifference0.1%

- Check75 days agoChange DetectedA site/interface revision indicator on the record history page was updated from version v3.5.2 to v3.5.3. This represents a background system/version change rather than a modification to the clinical trial record itself.SummaryDifference0.1%

Stay in the know with updates to FT538 with Daratumumab in AML Clinical Trial
Enter your email address, and we'll notify you when there's something new on the FT538 with Daratumumab in AML Clinical Trial page.